Data from the ZIPANGU study showed the use of focal/grid short-pulse laser therapy in patients receiving ranibizumab injections for the treatment of macular edema secondary to branch retinal vein occlusion did not reduce the number of necessary injections compared with patients undergoing ranibizumab monotherapy, according to a presenter at the virtual Association for Research in Vision and Ophthalmology meeting.
However, the study data suggested patients could experience similar visual acuity improvements with fewer injections when compared with data in previous clinical trials, Toshinori
Uncategorized